Review Of The Drug Enforcement Administration's (DEA)
Control Of The Diversion Of Controlled Pharmaceuticals
Report Number I-2002-010
September 2002
Diversion Control Program Organization and Staffing
Diversion Investigator Responsibilities
Diversion Control Program Funding
Insufficient Allocation of Investigative Resources to Controlled Pharmaceutical Diversion
Recommendation 1
Lack of Law Enforcement Authority for Diversion Investigators
Current DEA Policy Regarding the Role of the Diversion Investigator
Effect on the Quality of Diversion Investigations
Effect on the Timeliness of Diversion Investigations
Improving Investigative Capability
Recommendation 2
Recommendation 3
APPENDIX IDiversion Investigator work years for all types of investigations, 1993-2001 - [Not available electronically]
APPENDIX IIDiversion Investigator and Special Agent work years for controlled pharmaceutical and illicit drug investigations, 1993-2001
APPENDIX IIIPercentage of time spent by Diversion Investigators on all types of investigations, 1993-2001 - [Not available electronically]
APPENDIX IVDEA Management Response
APPENDIX VOffice of the Inspector General's Analysis of the DEA's Management Response